1-Methyl-2-oxo-4-[4-[4-(trifluoromethoxy)phenoxy]-1-piperidyl]-1,2-dihydroquinoline-3-carboxamide

1-Methyl-2-oxo-4-[4-[4-(trifluoromethoxy)phenoxy]-1-piperidyl]-1,2-dihydroquinoline-3-carboxamide Suppliers list
Company Name: Shanghai Beckham Medical Technology Co., Ltd  
Tel: 13816613772
Email: huahero21@sina.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: TargetMol Chemicals Inc.  
Tel: 13564774135
Email: marketing@targetmol.com

1-Methyl-2-oxo-4-[4-[4-(trifluoromethoxy)phenoxy]-1-piperidyl]-1,2-dihydroquinoline-3-carboxamide manufacturers

  • DGKα-IN-2
  • DGKα-IN-2 pictures
  • 2026-05-11
  • CAS:2648556-92-5
  • Purity:
  • Supply Ability: 10g
1-Methyl-2-oxo-4-[4-[4-(trifluoromethoxy)phenoxy]-1-piperidyl]-1,2-dihydroquinoline-3-carboxamide Basic information
Product Name:1-Methyl-2-oxo-4-[4-[4-(trifluoromethoxy)phenoxy]-1-piperidyl]-1,2-dihydroquinoline-3-carboxamide
Synonyms:1-Methyl-2-oxo-4-[4-[4-(trifluoromethoxy)phenoxy]-1-piperidyl]-1,2-dihydroquinoline-3-carboxamide;DGKα-IN-2;3-Quinolinecarboxamide, 1,2-dihydro-1-methyl-2-oxo-4-[4-[4-(trifluoromethoxy)phenoxy]-1-piperidinyl]-
CAS:2648556-92-5
MF:C23H22F3N3O4
MW:461.43
EINECS:
Product Categories:
Mol File:2648556-92-5.mol
1-Methyl-2-oxo-4-[4-[4-(trifluoromethoxy)phenoxy]-1-piperidyl]-1,2-dihydroquinoline-3-carboxamide Structure
1-Methyl-2-oxo-4-[4-[4-(trifluoromethoxy)phenoxy]-1-piperidyl]-1,2-dihydroquinoline-3-carboxamide Chemical Properties
Boiling point 576.187±50.00 °C(Press: 760.00 Torr)(predicted)
density 1.388±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
form Solid
pka14.716±0.20(predicted)
color White to off-white
Safety Information
MSDS Information
1-Methyl-2-oxo-4-[4-[4-(trifluoromethoxy)phenoxy]-1-piperidyl]-1,2-dihydroquinoline-3-carboxamide Usage And Synthesis
UsesDGKα-IN-2 (example 48) is a DGKα inhibitor with the IC50 of 0.9 nM, extracted from patent WO2021105115. DGKα-IN-2 significantly enhances the anti-tumor effect of anti-PD-1 by increasing the proliferation and function of T cells. DGKα-IN-2 has the potential for cancer and immunology study.
References[1] Schmees, Norbert, et al. Preparation of substituted aminoquinolones as DGKα inhibitors for immune activation. WO2021105115.
1-Methyl-2-oxo-4-[4-[4-(trifluoromethoxy)phenoxy]-1-piperidyl]-1,2-dihydroquinoline-3-carboxamide Preparation Products And Raw materials
Tag:1-Methyl-2-oxo-4-[4-[4-(trifluoromethoxy)phenoxy]-1-piperidyl]-1,2-dihydroquinoline-3-carboxamide(2648556-92-5) Related Product Information
COCHLIOQUINONE A 1,5-Naphthyridine-2-carbonitrile, 5,6-dihydro-3-(2-hydroxyethoxy)-5-methyl-8-[4-(5-methyl-2-benzoxazolyl)-1-piperidinyl]-6-oxo- 1H-[1,2,4]Triazolo[3,4-b]purine-1-ethanamine, 4-[(2S,5R)-4-[bis(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]-N,N-dimethyl- 8-[(2S,5R)-4-[Bis(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]-5-methyl-6-oxo-5,6-dihydro-1,5-naphthyridine-2-carbonitrile 1,5-Naphthyridine-2-carbonitrile, 8-[(2S,5R)-4-[bis(4-chlorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]-5,6-dihydro-5-methyl-6-oxo- 6-Fluoro-1-methyl-4-[4-(5-methyl-2-benzoxazolyl)-1-piperidyl]-2-oxo-1,2-dihydroquinoline-3-carboxamide